CTLA4 and cancer: This was based on the rationale that cancer vaccines induced antigen-specific T-cells to upregulate CTLA4, a negative regulatory molecule, and that CTLA4 blockade can prevent this and enhance T-cell-mediated immune responses to the vaccine.